Lung-RADS: Current Updates and Future Directions for Lung Cancer Screening Reporting

ACR Lung-RADS continues to evolve, with latest updates addressing volumetric vs. diameter measurement, sub-solid nodule management, Category 0 for infectious findings, and a new Atlas. Future directions include AI integration and risk-based approaches to refine lung cancer scree…

• Ongoing evaluation of volumetric vs. diameter-based nodule measurement and management of subsolid and juxtapleural nodules are active areas of committee discussion.
• The development of a Lung-RADS Atlas and a Category 0 designation for infectious or inflammatory findings reflect key refinements.
• Future research will explore incorporating artificial intelligence, risk-based assessment, incidental nodules, and international harmonization into the system.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.